stockrow
Friday 6 November 2026
Export DXCM’s income statement to Excel — free account
DexCom, Inc.
DXCM Healthcare Medical Devices
DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024.
- Revenue
- +11.2%
- EPS
- 0.00%
- Free cash flow
- −52.9%
- Total debt
- +0.31%
Quarter to September 2026, against a year earlier
79.50
4.96
−5.87%
Follow DXCM
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
3 | 5 | 3 | 5 | 5 | 5 | 6 | 7 | 5 | 8 |
P/E ratio |
0.00 | 0.00 | 0.00 | 200.70 | 71.65 | 281.07 | 130.38 | 87.30 | 52.90 | 30.87 |
Altman Z-Score |
24.43 | 6.53 | 5.62 | 9.12 | 9.90 | 12.21 | 9.43 | 8.52 | 5.72 | 6.43 |
P/S ratio |
8.49 | 6.97 | 10.24 | 13.50 | 18.11 | 21.21 | 15.35 | 13.12 | 7.59 | 5.56 |
P/FCF ratio |
9,737.73 | 192.52 | 188.35 | 148.17 | 126.15 | 19.10 | 146.62 | 92.82 | 48.53 | 24.04 |
Altman Z″-Score (non-manufacturers) |
(0.70) | 2.57 | 3.60 | 4.47 | 5.39 | 5.14 | 3.69 | 4.70 | 3.31 | 4.98 |
P/Operating CF |
366.08 | 121.49 | 313.54 | 138.69 | 202.86 | 490.90 | 337.18 | 355.63 | 101.56 | 88.09 |
Beneish M-Score |
(3.29) | (3.45) | (2.54) | (1.95) | (1.60) | (2.49) | (2.29) | (2.39) | (2.67) | (2.70) |
P/B ratio |
17.16 | 11.93 | 15.93 | 22.58 | 19.10 | 25.43 | 20.96 | 22.97 | 14.56 | 9.43 |
Price to Tangible BV |
17.87 | 12.29 | 16.39 | 23.07 | 19.54 | 26.18 | 23.11 | 24.89 | 15.49 | 9.77 |
EV/Sales |
8.28 | 6.66 | 9.88 | 13.19 | 17.58 | 20.92 | 15.19 | 13.25 | 7.45 | 5.56 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 101.93 | 92.39 | 139.25 | 80.77 | 61.24 | 36.74 | 22.27 |
EV/Operating CF |
84.47 | 52.02 | 82.73 | 61.91 | 71.21 | 115.74 | 66.00 | 64.12 | 30.36 | 17.99 |
EV/FCF |
9,494.53 | 184.08 | 181.69 | 144.75 | 122.45 | 18.83 | 145.03 | 93.76 | 47.63 | 24.06 |
Quick Ratio |
2.20 | 4.92 | 7.25 | 5.05 | 5.11 | 4.50 | 1.72 | 2.38 | 1.22 | 1.50 |
Current Ratio |
2.73 | 5.36 | 7.64 | 5.47 | 5.58 | 5.11 | 1.99 | 2.84 | 1.47 | 1.88 |
Net Debt/EBITDA |
2.41 | 8.37 | 2.39 | (2.41) | (2.79) | (1.98) | (0.89) | (0.37) | (1.64) | (0.65) |
Debt/Assets |
1.49% | 36.23% | 52.73% | 44.83% | 39.25% | 40.60% | 36.54% | 38.86% | 19.08% | 19.57% |
Debt/Equity |
0.02 | 0.78 | 1.52 | 1.22 | 0.92 | 0.98 | 0.92 | 1.18 | 0.59 | 0.45 |
Asset Turnover |
1.65 | 1.10 | 0.73 | 0.68 | 0.58 | 0.53 | 0.56 | 0.62 | 0.63 | 0.73 |
Operating CF/Net income |
(0.86) | (1.83) | (0.97) | 3.11 | 0.87 | 2.04 | 1.96 | 1.38 | 1.72 | 1.72 |
Capex/Depreciation |
(3.71) | (4.10) | (2.31) | (3.70) | (2.97) | 22.32 | (2.34) | (1.27) | (1.65) | (1.44) |
Interest Coverage |
(91.29) | (3.32) | (8.21) | 2.36 | 16.92 | 14.14 | 21.03 | — | — | — |
| (25.98%) | (14.28%) | (23.48%) | 13.08% | 40.58% | 11.21% | 16.35% | 25.78% | 27.63% | 34.50% | |
| (18.88%) | (7.68%) | (9.01%) | 4.69% | 16.44% | 4.70% | 6.61% | 9.29% | 9.04% | 13.04% | |
ROIC |
(24.04%) | (13.39%) | (40.43%) | 21.03% | 23.31% | 12.65% | 14.86% | 21.00% | 49.33% | 28.66% |
Return on Tangible Assets |
(22.86%) | (6.68%) | (7.66%) | 5.24% | 16.53% | 5.76% | 11.83% | 13.60% | 21.27% | 24.24% |
Average Days of Receivables |
64.75 | 68.22 | 80.21 | 70.80 | 81.18 | 76.67 | 89.48 | 98.13 | 91.02 | 95.21 |
Research and Development Expense of Revenue |
27.23% | 25.80% | 40.46% | 18.53% | 18.68% | 24.68% | 16.64% | 13.96% | 13.70% | 12.85% |
Selling, General and Administrative Expense of Revenue |
49.92% | 48.60% | 41.95% | 34.94% | 32.09% | 33.10% | 34.63% | 32.73% | 31.88% | 27.69% |
Intangible Assets out of Total Assets |
0.03 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.03 | 0.02 | 0.02 |
Share Based Compensation of Revenue |
19.33% | 14.78% | 9.88% | 6.96% | 6.20% | 4.63% | 4.35% | 4.16% | 4.23% | 3.42% |
Graham Net Nets |
0.03 | 0.05 | 0.04 | 0.02 | 0.03 | 0.02 | 0.01 | 0.00 | 0.00 | 0.02 |
Graham Number |
0.00 | 0.00 | 0.00 | 3.85 | 11.85 | 7.53 | 10.41 | 13.04 | 13.29 | 18.45 |
Earnings Yield |
(1.34%) | (1.02%) | (1.20%) | 0.50% | 1.40% | 0.36% | 0.77% | 1.15% | 1.89% | 3.24% |
Free Cash Flow Yield |
0.01% | 0.52% | 0.53% | 0.67% | 0.79% | 5.24% | 0.68% | 1.08% | 2.06% | 4.16% |
Revenue per Share |
1.71 | 2.08 | 2.92 | 4.05 | 5.10 | 6.33 | 7.47 | 9.38 | 10.25 | 11.95 |
Operating CF per Share |
0.17 | 0.27 | 0.35 | 0.86 | 1.26 | 1.14 | 1.72 | 1.94 | 2.51 | 3.69 |
Capex per Share |
(0.17) | (0.19) | (0.19) | (0.49) | (0.53) | 5.89 | (0.94) | (0.61) | (0.91) | (0.93) |
Free Cash Flow per Share |
0.00 | 0.08 | 0.16 | 0.37 | 0.73 | 7.03 | 0.78 | 1.33 | 1.60 | 2.76 |
Cash per Share |
0.37 | 1.59 | 3.93 | 4.21 | 7.17 | 7.06 | 6.31 | 7.06 | 6.55 | 5.12 |
Shareholders Equity per Share |
0.85 | 1.21 | 1.88 | 2.42 | 4.84 | 5.28 | 5.47 | 5.36 | 5.34 | 7.04 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.85 | 1.21 | 1.88 | 2.42 | 4.84 | 5.28 | 5.47 | 5.36 | 5.34 | 7.04 |
Free Cash Flow |
0.50 | 26.00 | 56.10 | 134.50 | 276.60 | 2,719.60 | 304.70 | 511.90 | 630.70 | 1,077.20 |
Working Capital |
177.60 | 605.80 | 1,477.10 | 1,609.20 | 2,810.70 | 2,963.60 | 1,829.50 | 2,869.90 | 1,369.40 | 1,890.80 |
Capital Expenditures |
(55.70) | (66.00) | (67.10) | (180.00) | (199.00) | 2,277.10 | (364.80) | (236.60) | (358.80) | (363.50) |
Net Current Asset Value |
161.00 | 260.00 | 446.80 | 457.00 | 960.80 | 793.20 | 408.90 | 230.00 | (80.50) | 439.40 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 136.82 | 113.08 | 192.68 | 112.96 | 80.30 | 50.07 | 28.42 |
Capex to Sales |
0.10 | 0.09 | 0.07 | 0.12 | 0.10 | (0.93) | 0.13 | 0.07 | 0.09 | 0.08 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 140.05 | 116.50 | 195.40 | 114.20 | 79.49 | 51.02 | 28.40 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.11 | 0.16 | 0.15 | 0.13 | 0.13 | 0.15 | 0.17 | 0.16 | 0.16 |
Cash ROIC |
0.12% | 2.01% | 1.83% | 3.85% | 4.45% | 40.14% | 4.65% | 7.08% | 10.66% | 18.00% |
Accounts Receivable Turnover |
6.52 | 6.09 | 5.72 | 5.75 | 5.39 | 5.19 | 4.74 | 4.29 | 4.07 | 4.20 |
Accounts Payable Turnover |
3.64 | 2.92 | 3.14 | 2.70 | 1.75 | 1.46 | 1.39 | 1.19 | 1.09 | 1.05 |
Inventory Turnover |
4.84 | 5.00 | 6.35 | 5.72 | 3.65 | 2.59 | 3.09 | 3.08 | 2.89 | 3.18 |
Average Days of Payables |
127.53 | 140.58 | 146.02 | 171.88 | 271.58 | 272.32 | 320.60 | 368.31 | 362.78 | 381.46 |
Days of Inventory on Hand |
85.02 | 72.87 | 70.18 | 80.31 | 132.49 | 169.81 | 109.03 | 153.18 | 124.18 | 123.45 |
Average Receivables |
87.90 | 118.00 | 180.50 | 256.50 | 357.40 | 471.40 | 613.80 | 843.60 | 989.80 | 1,110.90 |
Average Payables |
53.50 | 77.65 | 117.15 | 201.75 | 368.75 | 527.05 | 737.40 | 1,123.65 | 1,465.30 | 1,764.55 |
Average Inventory |
40.30 | 45.30 | 57.95 | 95.25 | 177.25 | 296.00 | 332.00 | 433.15 | 551.10 | 585.85 |
Average Assets |
347.40 | 653.45 | 1,410.05 | 2,155.50 | 3,342.75 | 4,611.90 | 5,162.50 | 5,828.10 | 6,374.50 | 6,412.20 |
Average Common Equity |
252.50 | 351.60 | 541.35 | 772.95 | 1,354.55 | 1,934.30 | 2,086.95 | 2,100.20 | 2,085.60 | 2,424.30 |
Columns are period end dates · fundamentals updated 5 Nov 2026